Bloomberg Law
July 1, 2022, 5:27 PM

Bausch + Lomb, Nicox Sue Gland Pharma to Block Generic Eye Drops

Christopher Yasiejko
Christopher Yasiejko

Bausch & Lomb Inc. and Nicox SA filed a federal lawsuit in New Jersey alleging a generic version of Vyzulta proposed by Gland Pharma Ltd. infringes four patents for the intraocular pressure-reducing eye drops.

Vyzulta, an ophthalmic solution with an active ingredient of latanoprostene bunod, is used to reduce such pressure in patients with open-angle glaucoma or ocular hypertension, according to a complaint filed Thursday in the US District Court for the District of New Jersey.

Gland is a unit of Shanghai Fosun Pharmaceutical Group Co.

Bausch & Lomb Ireland Ltd. exclusively licenses the patents from Nicox, with Bausch & ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.